Product
Hyperpolarized Carbon C 13 Pyruvate
Aliases
Hyperpolarized 13C-Pyruvate, Hyperpolarized Pyruvate (13C)
7 clinical trials
13 indications
Indication
Pancreatic Ductal AdenocarcinomaIndication
Prostate CancerIndication
Central Nervous System NeoplasmIndication
Prostate Cancer, Stage III AJCC v8Indication
Prostate Cancer Stage IIIB AJCC v8Indication
Brain NeoplasmIndication
Recurrent WHO Grade III GliomaIndication
GliomaIndication
Anaplastic AstrocytomaIndication
Thyroid CancerClinical trial
Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal AdenocarcinomaStatus: Terminated, Estimated PCD: 2022-11-01
Clinical trial
A Phase 2 Study of Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (13C) in Patients With Prostate Cancer on Active SurveillanceStatus: Recruiting, Estimated PCD: 2025-03-31
Clinical trial
A Pilot Study to Assess Lactate and Bicarbonate Detection Within Malignant Brain Tumors Using [1-13C]-Pyruvate DNP Magnetic Resonance Spectroscopy (MRS)Status: Completed, Estimated PCD: 2019-06-20
Clinical trial
Hyperpolarized 13-C-Pyruvate Magnetic Resonance Spectroscopic Imaging Reproducibilty Pilot in Patients With Prostate CancerStatus: Active (not recruiting), Estimated PCD: 2024-07-31
Clinical trial
Hyperpolarized Pyruvate Imaging of Glioma: Imaging-Pathological CorrelationStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Metabolic Imaging of Patients With Lower Grade Glioma Using Hyperpolarized 13C PyruvateStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Pilot Study of Metabolic Guidance for Therapy in Patients With Thyroid Cancer and Other Malignancies of the Head and NeckStatus: Recruiting, Estimated PCD: 2027-05-31